The ability to make quantitative measurements of MBF with positron-emission tomography (PET) allows to detect an impairment of vasodilatory capacity expressed by myocardial flow reserve (MFR) also in LV regions that are not subtended by a significantly obstructed artery in patients with angina and suspected CAD. 1-3 In the past decade, studies with PET have provided evidence that risk factors such as hypercholesterolemia, hypertension, diabetes mellitus, and smoking, in the absence of symptoms, translate into measurable damage to the coronary microcirculation involving the entire left ventricle. 2 The generator-produced 82 Rb is a very convenient tracer for measurement of MBF, because it does not require an on-site cyclotron and has a very short t1/2. Nowadays, improved scanner performance, iterative data reconstruction, and commercially available analysis software have enabled routine quantification of absolute myocardial blood flow (MBF) and MFR with good reproducibility among centers provided that dynamic time binning protocols and kinetic modeling are the same. 4-6 MPI with 82 Rb purports a high prognostic value which nowadays is well documented, 6-10 it would appear that MFR is a more robust parameter and less prone to methodological bias both in patients with overt CAD 11 and in non-obstructive lesions. 12 In the absence of epicardial lesions, impaired MFR is a hallmark of microvascular disease, undetectable at invasive or CT angiography, such as coronary allograft vasculopathy in